NT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Axicabtagene Ciloleucel or Post-Lisocabtagene Maraleucel in Subjects With Relapsed/Refractory Large B-cell Lymphoma
Conditions
Interventions
- DRUG: NT-I7
- BIOLOGICAL: CAR T-cell therapy
Sponsor
Washington University School of Medicine
Collaborators
- [object Object]
- [object Object]
- [object Object]